193 related articles for article (PubMed ID: 9539970)
21. Evidence for in vivo non-mutagenicity of the carcinogen hydrazine sulfate in target tissues of lacZ transgenic mice.
Douglas GR; Gingerich JD; Soper LM
Carcinogenesis; 1995 Apr; 16(4):801-4. PubMed ID: 7728958
[TBL] [Abstract][Full Text] [Related]
22. Integrated In Vivo Genotoxicity Assessment of Procarbazine Hydrochloride Demonstrates Induction of Pig-a and LacZ Mutations, and Micronuclei, in MutaMouse Hematopoietic Cells.
Maurice C; Dertinger SD; Yauk CL; Marchetti F
Environ Mol Mutagen; 2019 Jul; 60(6):505-512. PubMed ID: 30592561
[TBL] [Abstract][Full Text] [Related]
23. Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta Mouse).
Hakura A; Tsutsui Y; Sonoda J; Kai J; Imade T; Shimada M; Sugihara Y; Mikami T
Mutat Res; 1998 Feb; 398(1-2):123-30. PubMed ID: 9626972
[TBL] [Abstract][Full Text] [Related]
24. Relative activities of methyl methanesulphonate (MMS) as a genotoxin, clastogen and gene mutagen to the liver and bone marrow of MutaMouse mice.
Tinwell H; Lefevre PA; Ashby J
Environ Mol Mutagen; 1998; 32(2):163-72. PubMed ID: 9776179
[TBL] [Abstract][Full Text] [Related]
25. Quantitative dose-response analysis of ethyl methanesulfonate genotoxicity in adult gpt-delta transgenic mice.
Cao X; Mittelstaedt RA; Pearce MG; Allen BC; Soeteman-Hernández LG; Johnson GE; Bigger CA; Heflich RH
Environ Mol Mutagen; 2014 Jun; 55(5):385-99. PubMed ID: 24535894
[TBL] [Abstract][Full Text] [Related]
26. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice.
Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T
Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063
[TBL] [Abstract][Full Text] [Related]
27. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ).
Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK
Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317
[TBL] [Abstract][Full Text] [Related]
28. Response of the Muta mouse lacZ/galE- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responses.
Tinwell H; Lefevre PA; Ashby J
Mutat Res; 1994 May; 307(1):169-73. PubMed ID: 7513794
[TBL] [Abstract][Full Text] [Related]
29. Tissue-specific induction of mutations by streptozotocin in vivo.
Schmezer P; Eckert C; Liegibel UM
Mutat Res; 1994 Jun; 307(2):495-9. PubMed ID: 7514723
[TBL] [Abstract][Full Text] [Related]
30. Mutagenicity of ethyl carbamate to lacZ- transgenic mice.
Williams CV; Fletcher K; Tinwell H; Ashby J
Mutagenesis; 1998 Mar; 13(2):133-7. PubMed ID: 9568584
[TBL] [Abstract][Full Text] [Related]
31. Bioassay of quinoline, 5-fluoroquinoline, carbazole, 9-methylcarbazole and 9-ethylcarbazole in newborn mice.
Weyand EH; Defauw J; McQueen CA; Meschter CL; Meegalla SK; LaVoie EJ
Food Chem Toxicol; 1993 Oct; 31(10):707-15. PubMed ID: 8225128
[TBL] [Abstract][Full Text] [Related]
32. N-Nitrosodi-n-propylamine induces organ specific mutagenesis with specific expression times in lacZ transgenic mice.
Itoh S; Miura M; Itoh T; Miyauchi Y; Suga M; Takahashi Y; Kasahara Y; Yamamura E; Hirono H; Shimada H
Mutat Res; 1999 Aug; 444(2):309-19. PubMed ID: 10521671
[TBL] [Abstract][Full Text] [Related]
33. Quinoline: unscheduled DNA synthesis and mitogenesis data from the rat liver in vivo.
Ashby J; Mohammed R; Lefevre PA; Bandara L
Environ Mol Mutagen; 1989; 14(4):221-8. PubMed ID: 2511010
[TBL] [Abstract][Full Text] [Related]
34. Genotoxicity of fluoroquinolines and methylquinolines.
LaVoie EJ; Defauw J; Fealy M; Way BM; McQueen CA
Carcinogenesis; 1991 Feb; 12(2):217-20. PubMed ID: 1995188
[TBL] [Abstract][Full Text] [Related]
35. In vivo mutational analysis of liver DNA in gpt delta transgenic rats treated with the hepatocarcinogens N-nitrosopyrrolidine, 2-amino-3-methylimidazo[4,5-f]quinoline, and di(2-ethylhexyl)phthalate.
Kanki K; Nishikawa A; Masumura K; Umemura T; Imazawa T; Kitamura Y; Nohmi T; Hirose M
Mol Carcinog; 2005 Jan; 42(1):9-17. PubMed ID: 15486947
[TBL] [Abstract][Full Text] [Related]
36. Target organ and time-course in the mutagenicity of five carcinogens in MutaMouse: a summary report of the second collaborative study of the transgenic mouse mutation assay by JEMS/MMS.
Suzuki T; Itoh S; Nakajima M; Hachiya N; Hara T
Mutat Res; 1999 Aug; 444(2):259-68. PubMed ID: 10521667
[TBL] [Abstract][Full Text] [Related]
37. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
[TBL] [Abstract][Full Text] [Related]
38. Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice.
Butterworth BE; Templin MV; Constan AA; Sprankle CS; Wong BA; Pluta LJ; Everitt JI; Recio L
Environ Mol Mutagen; 1998; 31(3):248-56. PubMed ID: 9585263
[TBL] [Abstract][Full Text] [Related]
39. Somatic and germ cell mutagenesis in lambda lacZ transgenic mice treated with acrylamide or ethylnitrosourea.
Krebs O; Favor J
Mutat Res; 1997 Feb; 388(2-3):239-48. PubMed ID: 9057886
[TBL] [Abstract][Full Text] [Related]
40. Regional mutagenicity of heterocyclic amines in the intestine: mutation analysis of the cII gene in lambda/lacZ transgenic mice.
Itoh T; Kuwahara T; Suzuki T; Hayashi M; Ohnishi Y
Mutat Res; 2003 Aug; 539(1-2):99-108. PubMed ID: 12948818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
